Entrepreneurs must adopt a strategic funding approach that aligns with their startup's development milestones. Prudent planning and execution are crucial for success, and financial considerations play a critical role. A judicious methodology is essential for raising the necessary capital, ensuring viability and sustainability in the long term. Exploring the critical stages of funding your venture can help establish a roadmap that can guide you from conception to product launch.

The following blueprint can be used for tech start-ups in general and is not meant to be specific for the healthtech sector.

Seed Phase

In the seed phase, your venture is all about nurturing the seeds of your business idea. You are engrossed in idea generation, concept development, and feasibility studies. Financially speaking, the needs are modest, typically under EUR 1M. At this stage, you're most likely to rely on non-dilutive funding through grants or on F&F (friends and family)—who are enchanted by your vision enough to invest in its promising future.

Early-stage Phase

As your venture matures, it progresses into the early-stage phase. Your funding needs to burgeon to under EUR 5M as you draft your business plan, assemble an experienced team, and advance from prototyping to a solid proof of concept. Strategic collaborations can become a valuable source, as they are not only offering capital but also invaluable expertise and validation. Grants from public funds, as well as country and regional-specific funding opportunities, can help lower the need for dilutive capital. Angel investors, family offices (FOs), ultra-high-net-worth individuals (uHNWIs), and early-stage venture capitalists come into play, adding more substantial amounts of capital.

Late-stage Phase

Reaching the apex of growth, your venture blossoms into the late-stage phase, where you escalate development, begin manufacturing, and, in some cases, initiate revenue generation. Depending on the industry sector, funding needs can skyrocket to EUR 100M or more. Venture capital firms (VCs) and corporate venture capital (cVC) become crucial allies. Additional capital could be secured by going public with an IPO; however, this requires careful consideration and is a costly and lengthy process by itself. Private equity can aid in rapid scaling and launching a product, which could be followed by a business combination by a straight acquisition from a larger corporation, a merger between similar-sized companies, or a reverse merger between your private company and a listed public company in need of new assets or technology.

By syncing your funding sources with each stage of development, you ensure that your venture is not merely enduring but thriving.